Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1999 Aug;67(2):148–152. doi: 10.1136/jnnp.67.2.148

Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors

S Hawkins 1, G McDonnell 1
PMCID: PMC1736487  PMID: 10406979

Abstract

OBJECTIVE—To establish the characteristics of patients following a benign course of multiple sclerosis and evaluate the importance of potential prognostic factors. Also, an assessment of the value of the Kurtzke EDSS as a prognostic indicator has been undertaken in patients previously determined to have benign multiple sclerosis, after 10 years of follow up.
METHODS—A prevalence study in the Coleraine, Ballymena, Ballymoney, and Moyle districts of Northern Ireland used the Kurtzke expanded disability scale score (EDSS) in 259 patients with multiple sclerosis. Of these, 181 had had multiple sclerosis for⩾10 years, 36 having benign disease (EDSS⩽3.0) ⩾10 years after onset. Clinical and demographic details of the various patient groups, including the minimal record of disability, were compared. The 1987 study in Northern Ireland identified 33 patients with benign multiple sclerosis. Twenty eight were available for follow up in 1996 along with 42contemporary non-benign patients.
RESULTS—Patients with benign multiple sclerosis were predominantly women (ratio 4.1:1 v 2.1:1) and younger at onset (25.8 v 31.2 years). Commonest symptoms at onset were sensory and optic neuritis (33.3% each). Patients with late onset (older than 40 years) were less likely to have a benign course, more likely to have a progressive course from onset, significantly more likely to have motor disturbance at presentation, and had a lesser female predominance. Optic neuritis was significantly more common in those with a younger age at onset. In the follow up study, patients with benign multiple sclerosis continued to have a more favourable course than non-benign counterparts but progression of disability and to the secondary progressive phase remained significant. 
CONCLUSIONS—The association of female sex, early onset, and presentation with optic neuritis and sensory symptoms with a favourable course is confirmed. However, although the EDSS does provide a useful indicator of prognosis, the label "benign multiple sclerosis" is often temporary as apparently benign disease often becomes disabling.



Full Text

The Full Text of this article is available as a PDF (93.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAUER H. J., FIRNHABER W., WINKLER W. PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:542–551. doi: 10.1111/j.1749-6632.1965.tb20234.x. [DOI] [PubMed] [Google Scholar]
  2. Confavreux C., Aimard G., Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain. 1980 Jun;103(2):281–300. doi: 10.1093/brain/103.2.281. [DOI] [PubMed] [Google Scholar]
  3. Detels R., Clark V. A., Valdiviezo N. L., Visscher B. R., Malmgren R. M., Dudley J. P. Factors associated with a rapid course of multiple sclerosis. Arch Neurol. 1982 Jun;39(6):337–341. doi: 10.1001/archneur.1982.00510180015003. [DOI] [PubMed] [Google Scholar]
  4. Fog T., Linnemann F. The course of multiple sclerosis in 73 cases with computer-designed curves. Acta Neurol Scand Suppl. 1970;47:3–175. [PubMed] [Google Scholar]
  5. Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Arch Neurol. 1983 Sep;40(9):533–536. doi: 10.1001/archneur.1983.04050080033003. [DOI] [PubMed] [Google Scholar]
  6. Herndon R. M., Rudick R. A. Multiple sclerosis. The spectrum of severity. Arch Neurol. 1983 Sep;40(9):531–532. doi: 10.1001/archneur.1983.04050080031002. [DOI] [PubMed] [Google Scholar]
  7. Hutchinson M. Disability due to multiple sclerosis: a community-based study on an Irish county. Ir Med J. 1986 Feb;79(2):48–50. [PubMed] [Google Scholar]
  8. Kurtzke J. F., Beebe G. W., Nagler B., Kurland L. T., Auth T. L. Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness. J Chronic Dis. 1977 Dec;30(12):819–830. doi: 10.1016/0021-9681(77)90010-8. [DOI] [PubMed] [Google Scholar]
  9. Leibowitz U., Alter M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand. 1970;46(1):53–70. doi: 10.1111/j.1600-0404.1970.tb05604.x. [DOI] [PubMed] [Google Scholar]
  10. Lublin F. D., Reingold S. C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 Apr;46(4):907–911. doi: 10.1212/wnl.46.4.907. [DOI] [PubMed] [Google Scholar]
  11. MCALPINE D. THE BENIGN FORM OF MULTIPLE SCLEROSIS: RESULTS OF A LONG-TERM STUDY. Br Med J. 1964 Oct 24;2(5416):1029–1032. doi: 10.1136/bmj.2.5416.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MCALPINE D. The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain. 1961 Jun;84:186–203. doi: 10.1093/brain/84.2.186. [DOI] [PubMed] [Google Scholar]
  13. McALPINE D., COMPSTON N. Some aspects of the natural history of disseminated sclerosis. Q J Med. 1952 Apr;21(82):135–167. [PubMed] [Google Scholar]
  14. McDonnell G. V., Hawkins S. A. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology. 1998 Feb;50(2):423–428. doi: 10.1212/wnl.50.2.423. [DOI] [PubMed] [Google Scholar]
  15. O'Riordan J. I., Thompson A. J., Kingsley D. P., MacManus D. G., Kendall B. E., Rudge P., McDonald W. I., Miller D. H. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain. 1998 Mar;121(Pt 3):495–503. doi: 10.1093/brain/121.3.495. [DOI] [PubMed] [Google Scholar]
  16. Patzold U., Pocklington P. R. Course of multiple sclerosis. First results of a prospective study carried out of 102 MS patients from 1976-1980. Acta Neurol Scand. 1982 Apr;65(4):248–266. doi: 10.1111/j.1600-0404.1982.tb03084.x. [DOI] [PubMed] [Google Scholar]
  17. Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., Johnson K. P., Sibley W. A., Silberberg D. H., Tourtellotte W. W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 Mar;13(3):227–231. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  18. Poser S., Bauer H. J., Poser W. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany. Acta Neurol Scand. 1982 Apr;65(4):347–354. doi: 10.1111/j.1600-0404.1982.tb03091.x. [DOI] [PubMed] [Google Scholar]
  19. Poser S., Wikström J., Bauer H. J. Clinical data and the identification of special forms of multiple sclerosis in 1271 cases studied with a standardized documentation system. J Neurol Sci. 1979 Feb;40(2-3):159–168. doi: 10.1016/0022-510x(79)90201-6. [DOI] [PubMed] [Google Scholar]
  20. Riser M., Géraud J., Rascol A., Benazet A. M., Segria M. G. L'évolution de la sclérose en plaques. Etude de 203 observations suivies au-delà de 10 ans. Rev Neurol (Paris) 1971 Jun;124(6):479–486. [PubMed] [Google Scholar]
  21. Runmarker B., Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 Feb;116(Pt 1):117–134. doi: 10.1093/brain/116.1.117. [DOI] [PubMed] [Google Scholar]
  22. Sadovnick A. D., Armstrong H., Rice G. P., Bulman D., Hashimoto L., Paty D. W., Hashimoto S. A., Warren S., Hader W., Murray T. J. A population-based study of multiple sclerosis in twins: update. Ann Neurol. 1993 Mar;33(3):281–285. doi: 10.1002/ana.410330309. [DOI] [PubMed] [Google Scholar]
  23. Sanders E. A., Bollen E. L., van der Velde E. A. Presenting signs and symptoms in multiple sclerosis. Acta Neurol Scand. 1986 Mar;73(3):269–272. doi: 10.1111/j.1600-0404.1986.tb03274.x. [DOI] [PubMed] [Google Scholar]
  24. Thompson A. J., Hutchinson M., Brazil J., Feighery C., Martin E. A. A clinical and laboratory study of benign multiple sclerosis. Q J Med. 1986 Jan;58(225):69–80. [PubMed] [Google Scholar]
  25. Verjans E., Theys P., Delmotte P., Carton H. Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I. J Neurol. 1983;229(3):155–165. doi: 10.1007/BF00313739. [DOI] [PubMed] [Google Scholar]
  26. Visscher B. R., Liu K. S., Clark V. A., Detels R., Malmgren R. M., Dudley J. P. Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand. 1984 Nov;70(5):321–328. doi: 10.1111/j.1600-0404.1984.tb00832.x. [DOI] [PubMed] [Google Scholar]
  27. Weinshenker B. G., Rice G. P., Noseworthy J. H., Carriere W., Baskerville J., Ebers G. C. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain. 1991 Apr;114(Pt 2):1045–1056. doi: 10.1093/brain/114.2.1045. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES